Pharmabiz

Meitheal Pharmaceuticals receives US FDA approval for Garzulys injection

Meitheal Pharmaceuticals receives US FDA approval for Garzulys injection: Chicago Saturday, August 1, 2026, 15:00 Hrs [IST] Meitheal Pharmaceuticals Inc (Meitheal), a fully integr ...
Pharmabiz

Karyopharm to submit sNDA to US FDA in Aug 2026 seeking accelerated approval of selinexor in combo with ruxolitinib to treat myelofibrosis

Karyopharm to submit sNDA to US FDA in Aug 2026 seeking accelerated approval of selinexor in combo with ruxolitinib to treat myelofibrosis: Newton, Massachusetts Saturday, August ...
Pharmabiz

AstraZeneca & Daiichi Sankyo’s Datroway receives European approval for 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy

AstraZeneca & Daiichi Sankyo’s Datroway receives European approval for 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy: Cambridge, U ...
Pharmabiz

Chugai files for additional indication of Enspryng as Japan’s potential first treatment for prevention of relapse in MOG antibody-associated disease

Chugai files for additional indication of Enspryng as Japan’s potential first treatment for prevention of relapse in MOG antibody-associated disease: Tokyo Saturday, August 1, 2 ...
Pharmabiz

Atavistik Bio partners with Cure HHT Clinical Trial Network to advance development of ATV-1601 for hereditary haemorrhagic telangiectasia

Atavistik Bio partners with Cure HHT Clinical Trial Network to advance development of ATV-1601 for hereditary haemorrhagic telangiectasia: Cambridge, Massachusetts Saturday, Augus ...
Pharmabiz

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine: Our Bureau, Mumbai Saturday, August 1, 2026, 14:15 Hrs [IST] In a significant step t ...
Pharmabiz

Replimune announces favourable outcome from US FDA’s Advisory Committee meeting for RP1 in advanced melanoma

Replimune announces favourable outcome from US FDA’s Advisory Committee meeting for RP1 in advanced melanoma: Woburn, Massachusetts Saturday, August 1, 2026, 16:00 Hrs [IST] Rep ...
Pharmabiz

US FDA grants priority review status to Johnson & Johnson’s sBLA for Rybrevant Faspro for adults with recurrent or metastatic HNSCC

US FDA grants priority review status to Johnson & Johnson’s sBLA for Rybrevant Faspro for adults with recurrent or metastatic HNSCC: Raritan, New Jersey Saturday, August 1, 2026 ...
Pharmabiz

US FDA clears Iksuda Therapeutics’ IND application for IKS04, a CA242-directed ADC to treat patients with GI cancers

US FDA clears Iksuda Therapeutics’ IND application for IKS04, a CA242-directed ADC to treat patients with GI cancers: Newcastle, UK Saturday, August 1, 2026, 17:00 Hrs [IST] Iks ...
Pharmabiz

Stevanato Group's Alina pen injector receives European marketing authorizations

Stevanato Group's Alina pen injector receives European marketing authorizations: Piombino Dese, Italy Stevanato Group S.p.A., a leading g ...
Pharmabiz

Kaigene inks licensing agreement with Taisho Pharma for next-generation autoimmune asset ‘KG006’ in Japan

Kaigene inks licensing agreement with Taisho Pharma for next-generation autoimmune asset ‘KG006’ in Japan: Rockville Saturday, August 1, 2026, 10:00 Hrs [IST] Kaigene Inc, a U ...
Pharmabiz

Corona Remedies Q1 net profit rises 30%

Corona Remedies Limited, a leading India-focused branded pharmaceutical company, announced its unaudited financial results for Q1FY27, delivering robust revenue, and resilient margins, supported by ...